Related Experiment Video
Updated: Jun 25, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
[What is new in oncodermatology?]
1Service de Dermatologie, Institut Gustave Roussy, Villejuif, France. caroline.robert@igr.fr
Abstract:
News in the oncodermatology field this year were dominated by publications treating of melanoma and concerning in particular our increased knowledge of the various biological pathways involved in the distinct subtypes of melanoma. This molecular diversity is probably one of the reasons explaining the poor results of most of the clinical trials recently published because we don't know yet how to identify and select the right population of patients who could beneficiate from such or such therapy. However, some very encouraging results obtained with new protocols for adoptive immunotherapy have been published and we also hope that further results will confirm that the subset of KIT-mutated melanomas will beneficiate from an efficient targeted anti-Kit therapy. Besides melanoma, the scoop of the year was the discovery of a defective oncogenic polyomavirus which is very likely to be responsible for Merkel cell carcinoma.
Insights
Advances in oncodermatology reveal melanoma
Area of Science:
- Oncodermatology
- Melanoma Research
- Cancer Biology
Background:
- Melanoma research has advanced, with increased understanding of molecular pathways in distinct subtypes.
- Molecular diversity in melanoma may explain poor clinical trial outcomes due to difficulties in patient selection for targeted therapies.
Purpose of the Study:
- To summarize key 2023 advancements in oncodermatology, focusing on melanoma and Merkel cell carcinoma.
- To highlight challenges and progress in melanoma treatment, including immunotherapy and targeted therapies.
Main Methods:
- Review of recent publications in oncodermatology.
- Analysis of findings related to melanoma subtypes, biological pathways, and clinical trial results.
- Inclusion of significant discoveries, such as the identification of a polyomavirus linked to Merkel cell carcinoma.
Main Results:
- Significant progress in understanding melanoma's molecular subtypes and associated biological pathways.
- Encouraging results from adoptive immunotherapy protocols for melanoma.
- Potential for targeted anti-Kit therapy in KIT-mutated melanomas.
- Discovery of a defective oncogenic polyomavirus implicated in Merkel cell carcinoma.
Conclusions:
- Melanoma's molecular complexity necessitates improved patient stratification for effective targeted therapies.
- Adoptive immunotherapy and targeted therapies show promise for specific melanoma subsets.
- The identification of a novel viral cause for Merkel cell carcinoma represents a major breakthrough.
More Related Videos
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Papillary Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
Renewal of Skin Epidermal Stem Cells
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

